This training toolkit is intended to focus on building the capacity of health care workers at the primary and secondary level to address and manage TB in children through the objectives of: 1) increasing the detection of TB in children with TB in the community, 2) improving the management of children with TB, 3) increase implementation of child contact screening and preventative therapy, and 4) provide accurate data on childhood TB for better monitoring and evaluation.
2016 is the first year of implementation of the WHO End TB Strategy in the context of the United Nations Sustainable Development Goals Agenda, both of which include the aim of ending the TB epidemic. To support the work ahead, the World Health Organization’s Global TB Programme has developed operational guidance, The Essentials, for effective adaptation and implementation of the new Strategy. The Essentials provides in-depth explanations of the vision, goal, targets, and milestones of the End TB Strategy, as well as key indicators to measure progress.
WHO guidelines on HIV and Infant Feeding in 2010 for the first time recommended the use of antiretroviral drugs to prevent postnatal transmission of HIV through breastfeeding. This resulted in a major change from an individualised counselling approach toward a public health approach regarding how maternal and child health services should routinely promote and support infant feeding practices among mothers living with HIV
This guide includes WHO recommendations on screening and treatment of pre-cancer lesions and on HPV vaccination made through April 2014, taking account of relevant evidence-based findings published up to December 2013; emerging practices that are still being evaluated are also noted in this publication. This guide, which replaces the 2006 edition, has two new chapters, one newly organized chapter, and two substantially revised chapters. The new chapters include: Essentials for cervical a=cancer prevention and control programmes; and HPV vaccination.
This monograph is a guide to monitoring and evaluating the collaborative TB/HIV activities. It presents a rationale for collaborative activities, an overview of monitoring indicators, methods of collecting standardized data, and help in interpreting and disseminating the data. It argues for consistency in the way collaborative activities are performed and data collected. The guide presents a core set of internationally accepted and standardized indicators for measuring and evaluating performance.
This report gives the results of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance (DRS), conducted between 1996 and 1999, three years after the initial survey of 35 geographical settings, with the aim of collecting worldwide information on drug resistance of Mycobacterium TB.